Industry: Service & Software
Published Date: 2024-11-29
Pages: 94 Pages
Report ld: 3388192
Request Sample
Customized Report
AI-Assisted Drug Discovery Software Market Size(US$)

CAGR 2024-2030
8.6%
Market Size,2030
USD 1,221
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global AI-Assisted Drug Discovery Software revenue was US$ 685 million in 2023 and is forecast to a readjusted size of US$ 1221 million by 2030 with a CAGR of 8.6% during the review period (2024-2030).
In United States the AI-Assisted Drug Discovery Software revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States AI-Assisted Drug Discovery Software market, also covers the segmentation data of other regions in regional level and county level.
AI-AssistedDrug Discovery Software refers to a software system that uses artificial intelligence technology, based on pharmaceutical big data, to quickly analyze drug structure, efficacy, etc. through machine learning, deep learning and other technologies. This type of software is designed to shorten the drug development cycle, save costs, promote new drug discovery and improve the success rate of trials.
The global key players of AI-Assisted Drug Discovery Software include AIDDISON, Atomwise Inc, BenevolentAI, BullFrog AI, Cyclica, Exscientia, Genesis Therapeutics Inc, Insilico Medicine, Recursion Pharmaceuticals, Verge Genomics, etc. The global five biggest players hold a share of % in 2023.
Global AI-Assisted Drug Discovery Software Scope and Market Size
AI-Assisted Drug Discovery Software market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global AI-Assisted Drug Discovery Software market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the AI-Assisted Drug Discovery Software market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces AI-Assisted Drug Discovery Software definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of AI-Assisted Drug Discovery Software companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue of AI-Assisted Drug Discovery Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6: Americas by Type, by Application and by country, revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI-Assisted Drug Discovery Software revenue, gross margin, and recent development, etc.
Chapter 11: Analyst's Viewpoints/Conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 AI-Assisted Drug Discovery Software Product Introduction
1.2 Global AI-Assisted Drug Discovery Software Outlook, 2019 VS 2023 VS 2030
1.2.1 Global AI-Assisted Drug Discovery Software Market Size for the Year 2019-2030
1.2.2 United States AI-Assisted Drug Discovery Software Market Size for the Year 2019-2030
1.3 AI-Assisted Drug Discovery Software Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.3.1 The Market Share of United States AI-Assisted Drug Discovery Software in Global, 2019 VS 2023 VS 2030
1.3.2 The Growth Rate of AI-Assisted Drug Discovery Software Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4 AI-Assisted Drug Discovery Software Market Dynamics
1.4.1 AI-Assisted Drug Discovery Software Industry Trends
1.4.2 AI-Assisted Drug Discovery Software Market Drivers
1.4.3 AI-Assisted Drug Discovery Software Market Challenges
1.4.4 AI-Assisted Drug Discovery Software Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 AI-Assisted Drug Discovery Software by Type
2.1 AI-Assisted Drug Discovery Software Market by Type
2.1.1 On Premise Software
2.1.2 Cloud-Based Software
2.2 Global AI-Assisted Drug Discovery Software Market Size by Type (2019, 2023 & 2030)
2.3 Global AI-Assisted Drug Discovery Software Market Size by Type (2019-2030)
2.4 United States AI-Assisted Drug Discovery Software Market Size by Type (2019, 2023 & 2030)
2.5 United States AI-Assisted Drug Discovery Software Market Size by Type (2019-2030)
3 AI-Assisted Drug Discovery Software by Application
3.1 AI-Assisted Drug Discovery Software Market by Application
3.1.1 Biopharmaceuticals
3.1.2 Pharmaceuticals
3.1.3 Others
3.2 Global AI-Assisted Drug Discovery Software Market Size, by Application (2019, 2023 & 2030)
3.3 Global AI-Assisted Drug Discovery Software Market Size by Application (2019-2030)
3.4 United States AI-Assisted Drug Discovery Software Market Size by Application (2019, 2023 & 2030)
3.5 United States AI-Assisted Drug Discovery Software Market Size by Application (2019-2030)
4 Global AI-Assisted Drug Discovery Software Competitor Landscape by Company
4.1 Global AI-Assisted Drug Discovery Software Market Size by Company
4.1.1 Global Key Companies of AI-Assisted Drug Discovery Software, Ranked by Revenue (2023)
4.1.2 Global AI-Assisted Drug Discovery Software Revenue by Player (2019-2024)
4.2 Global AI-Assisted Drug Discovery Software Concentration Ratio (CR)
4.2.1 AI-Assisted Drug Discovery Software Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Companies of AI-Assisted Drug Discovery Software in 2023
4.2.3 Global AI-Assisted Drug Discovery Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of AI-Assisted Drug Discovery Software Head office and Area Served
4.4 Global Key Players of AI-Assisted Drug Discovery Software, Product and Application
4.5 Global Key Players of AI-Assisted Drug Discovery Software, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States AI-Assisted Drug Discovery Software Market Size by Company
4.7.1 Key Players of AI-Assisted Drug Discovery Software in United States, Ranked by Revenue (2023)
4.7.2 United States AI-Assisted Drug Discovery Software Revenue by Players (2022, 2023 & 2024)
5 Global AI-Assisted Drug Discovery Software Market Size by Region
5.1 Global AI-Assisted Drug Discovery Software Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global AI-Assisted Drug Discovery Software Market Size by Region (2019-2030)
5.2.1 Global AI-Assisted Drug Discovery Software Market Size by Region: 2019-2024
5.2.2 Global AI-Assisted Drug Discovery Software Market Size by Region: 2025-2030
6 Americas
6.1 Americas AI-Assisted Drug Discovery Software Market Size YoY Growth 2019-2030
6.2 Americas AI-Assisted Drug Discovery Software Market Size by Type
6.2.1 Americas AI-Assisted Drug Discovery Software Market Size by Type (2019-2024)
6.2.2 Americas AI-Assisted Drug Discovery Software Market Size by Type (2025-2030)
6.2.3 Americas AI-Assisted Drug Discovery Software Market Share by Type (2019-2030)
6.3 Americas AI-Assisted Drug Discovery Software Market Size by Application
6.3.1 Americas AI-Assisted Drug Discovery Software Market Size by Application (2019-2024)
6.3.2 Americas AI-Assisted Drug Discovery Software Market Size by Application (2025-2030)
6.3.3 Americas AI-Assisted Drug Discovery Software Market Share by Application (2019-2030)
6.4 Americas AI-Assisted Drug Discovery Software Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA AI-Assisted Drug Discovery Software Market Size YoY Growth 2019-2030
7.2 EMEA AI-Assisted Drug Discovery Software Market Size by Type
7.2.1 EMEA AI-Assisted Drug Discovery Software Market Size by Type (2019-2024)
7.2.2 EMEA AI-Assisted Drug Discovery Software Market Size by Type (2025-2030)
7.2.3 EMEA AI-Assisted Drug Discovery Software Market Share by Type (2019-2030)
7.3 EMEA AI-Assisted Drug Discovery Software Market Size by Application
7.3.1 EMEA AI-Assisted Drug Discovery Software Market Size by Application (2019-2024)
7.3.2 EMEA AI-Assisted Drug Discovery Software Market Size by Application (2025-2030)
7.3.3 EMEA AI-Assisted Drug Discovery Software Market Share by Application (2019-2030)
7.4 EMEA AI-Assisted Drug Discovery Software Market Facts & Figures by Region (2019, 2023 & 2030)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China AI-Assisted Drug Discovery Software Market Size by Type
8.1.1 China AI-Assisted Drug Discovery Software Market Size by Type (2019-2024)
8.1.2 China AI-Assisted Drug Discovery Software Market Size by Type (2025-2030)
8.1.3 China AI-Assisted Drug Discovery Software Market Share by Type (2019-2030)
8.2 China AI-Assisted Drug Discovery Software Market Size by Application
8.2.1 China AI-Assisted Drug Discovery Software Market Size by Application (2019-2024)
8.2.2 China AI-Assisted Drug Discovery Software Market Size by Application (2025-2030)
8.2.3 China AI-Assisted Drug Discovery Software Market Share by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC AI-Assisted Drug Discovery Software Market Size YoY Growth 2019-2030
9.2 APAC AI-Assisted Drug Discovery Software Market Size by Type
9.2.1 APAC AI-Assisted Drug Discovery Software Market Size by Type (2019-2024)
9.2.2 APAC AI-Assisted Drug Discovery Software Market Size by Type (2025-2030)
9.2.3 APAC AI-Assisted Drug Discovery Software Market Share by Type (2019-2030)
9.3 APAC AI-Assisted Drug Discovery Software Market Size by Application
9.3.1 APAC AI-Assisted Drug Discovery Software Market Size by Application (2019-2024)
9.3.2 APAC AI-Assisted Drug Discovery Software Market Size by Application (2025-2030)
9.3.3 APAC AI-Assisted Drug Discovery Software Market Share by Application (2019-2030)
9.4 APAC AI-Assisted Drug Discovery Software Market Facts & Figures by Region (2019, 2023 & 2030)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 ASEAN
9.4.5 India
10 Key Players Profiles
10.1 AIDDISON
10.1.1 AIDDISON Company Details
10.1.2 AIDDISON Business Overview
10.1.3 AIDDISON AI-Assisted Drug Discovery Software Introduction
10.1.4 AIDDISON Revenue in AI-Assisted Drug Discovery Software Business (2019-2024)
10.1.5 AIDDISON Recent Development
10.2 Atomwise Inc
10.2.1 Atomwise Inc Company Details
10.2.2 Atomwise Inc Business Overview
10.2.3 Atomwise Inc AI-Assisted Drug Discovery Software Introduction
10.2.4 Atomwise Inc Revenue in AI-Assisted Drug Discovery Software Business (2019-2024)
10.2.5 Atomwise Inc Recent Development
10.3 BenevolentAI
10.3.1 BenevolentAI Company Details
10.3.2 BenevolentAI Business Overview
10.3.3 BenevolentAI AI-Assisted Drug Discovery Software Introduction
10.3.4 BenevolentAI Revenue in AI-Assisted Drug Discovery Software Business (2019-2024)
10.3.5 BenevolentAI Recent Development
10.4 BullFrog AI
10.4.1 BullFrog AI Company Details
10.4.2 BullFrog AI Business Overview
10.4.3 BullFrog AI AI-Assisted Drug Discovery Software Introduction
10.4.4 BullFrog AI Revenue in AI-Assisted Drug Discovery Software Business (2019-2024)
10.4.5 BullFrog AI Recent Development
10.5 Cyclica
10.5.1 Cyclica Company Details
10.5.2 Cyclica Business Overview
10.5.3 Cyclica AI-Assisted Drug Discovery Software Introduction
10.5.4 Cyclica Revenue in AI-Assisted Drug Discovery Software Business (2019-2024)
10.5.5 Cyclica Recent Development
10.6 Exscientia
10.6.1 Exscientia Company Details
10.6.2 Exscientia Business Overview
10.6.3 Exscientia AI-Assisted Drug Discovery Software Introduction
10.6.4 Exscientia Revenue in AI-Assisted Drug Discovery Software Business (2019-2024)
10.6.5 Exscientia Recent Development
10.7 Genesis Therapeutics Inc
10.7.1 Genesis Therapeutics Inc Company Details
10.7.2 Genesis Therapeutics Inc Business Overview
10.7.3 Genesis Therapeutics Inc AI-Assisted Drug Discovery Software Introduction
10.7.4 Genesis Therapeutics Inc Revenue in AI-Assisted Drug Discovery Software Business (2019-2024)
10.7.5 Genesis Therapeutics Inc Recent Development
10.8 Insilico Medicine
10.8.1 Insilico Medicine Company Details
10.8.2 Insilico Medicine Business Overview
10.8.3 Insilico Medicine AI-Assisted Drug Discovery Software Introduction
10.8.4 Insilico Medicine Revenue in AI-Assisted Drug Discovery Software Business (2019-2024)
10.8.5 Insilico Medicine Recent Development
10.9 Recursion Pharmaceuticals
10.9.1 Recursion Pharmaceuticals Company Details
10.9.2 Recursion Pharmaceuticals Business Overview
10.9.3 Recursion Pharmaceuticals AI-Assisted Drug Discovery Software Introduction
10.9.4 Recursion Pharmaceuticals Revenue in AI-Assisted Drug Discovery Software Business (2019-2024)
10.9.5 Recursion Pharmaceuticals Recent Development
10.10 Verge Genomics
10.10.1 Verge Genomics Company Details
10.10.2 Verge Genomics Business Overview
10.10.3 Verge Genomics AI-Assisted Drug Discovery Software Introduction
10.10.4 Verge Genomics Revenue in AI-Assisted Drug Discovery Software Business (2019-2024)
10.10.5 Verge Genomics Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global AI-Assisted Drug Discovery Software market is projected to grow from US$ 802 million in 2025 to US$ 1417 million by 2032, at a CAGR of 8.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-25
Pages: 130
USD 4900.00
(Single User License)
The global AI-Assisted Drug Discovery Software market size was US$ 802 million in 2025 and is forecast to reach a readjusted size of US$ 1417 million by 2032 with a CAGR of 8.6% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 76
USD 4250.00
(Single User License)
The global AI-Assisted Drug Discovery Software market was valued at US$ 802 million in 2025 and is anticipated to reach US$ 1417 million by 2032, at a CAGR of 8.6% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 109
USD 2900.00
(Single User License)
The global market for AI-Assisted Drug Discovery Software was estimated to be worth US$ 802 million in 2025 and is projected to reach US$ 1417 million, growing at a CAGR of 8.6% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 99
USD 3950.00
(Single User License)
The global AI-Assisted Drug Discovery Software market size was US$ 744 million in 2024 and is forecast to a readjusted size of US$ 1315 million by 2031 with a CAGR of 8.6% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 77
USD 4250.00
(Single User License)
The global AI-Assisted Drug Discovery Software market is projected to grow from US$ 744 million in 2024 to US$ 1315 million by 2031, at a CAGR of 8.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-01
Pages: 124
USD 4900.00
(Single User License)
The global market for AI-Assisted Drug Discovery Software was estimated to be worth US$ 744 million in 2024 and is forecast to a readjusted size of US$ 1315 million by 2031 with a CAGR of 8.6% during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 81
USD 3950.00
(Single User License)
The global market for AI-Assisted Drug Discovery Software was valued at US$ 744 million in the year 2024 and is projected to reach a revised size of US$ 1315 million by 2031, growing at a CAGR of 8.6% during the forecast period.
Published Date: 2025-03-12
Pages: 74
USD 2900.00
(Single User License)
Valued at US$ 744 million in 2024, the global AI-Assisted Drug Discovery Software market is forecast to reach US$ 1221 million by 2030, at a CAGR of 8.6% during the forecast period.
Published Date: 2024-11-29
Pages: 123
USD 4900.00
(Single User License)
The global market for AI-Assisted Drug Discovery Software was estimated to be worth US$ 685 million in 2023 and is forecast to a readjusted size of US$ 1221 million by 2030 with a CAGR of 8.6% during the forecast period 2024-2030.
Published Date: 2024-11-29
Pages: 88
USD 3950.00
(Single User License)
The global AI-Assisted Drug Discovery Software market is projected to grow from US$ 802 million in 2025 to US$ 1417 million by 2032, at a CAGR of 8.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-25
Pages: 130
The global AI-Assisted Drug Discovery Software market size was US$ 802 million in 2025 and is forecast to reach a readjusted size of US$ 1417 million by 2032 with a CAGR of 8.6% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 76
The global AI-Assisted Drug Discovery Software market was valued at US$ 802 million in 2025 and is anticipated to reach US$ 1417 million by 2032, at a CAGR of 8.6% from 2026 to 2032.
Published: 2026-01-08
Pages: 109
The global market for AI-Assisted Drug Discovery Software was estimated to be worth US$ 802 million in 2025 and is projected to reach US$ 1417 million, growing at a CAGR of 8.6% from 2026 to 2032.
Published: 2026-01-08
Pages: 99
The global AI-Assisted Drug Discovery Software market size was US$ 744 million in 2024 and is forecast to a readjusted size of US$ 1315 million by 2031 with a CAGR of 8.6% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 77
The global AI-Assisted Drug Discovery Software market is projected to grow from US$ 744 million in 2024 to US$ 1315 million by 2031, at a CAGR of 8.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-01
Pages: 124
The global market for AI-Assisted Drug Discovery Software was estimated to be worth US$ 744 million in 2024 and is forecast to a readjusted size of US$ 1315 million by 2031 with a CAGR of 8.6% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 81
The global market for AI-Assisted Drug Discovery Software was valued at US$ 744 million in the year 2024 and is projected to reach a revised size of US$ 1315 million by 2031, growing at a CAGR of 8.6% during the forecast period.
Published: 2025-03-12
Pages: 74
Valued at US$ 744 million in 2024, the global AI-Assisted Drug Discovery Software market is forecast to reach US$ 1221 million by 2030, at a CAGR of 8.6% during the forecast period.
Published: 2024-11-29
Pages: 123
The global market for AI-Assisted Drug Discovery Software was estimated to be worth US$ 685 million in 2023 and is forecast to a readjusted size of US$ 1221 million by 2030 with a CAGR of 8.6% during the forecast period 2024-2030.
Published: 2024-11-29
Pages: 88
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now